PT  - JOURNAL ARTICLE
AU  - GEORGE J. DELINASIOS
AU  - PARASKEVI C. FRAGKOU
AU  - ATHINA M. GKIRMPA
AU  - GEORGE TSANGARIS
AU  - ROBERT M. HOFFMAN
AU  - ATHANASIOS K. ANAGNOSTOPOULOS
TI  - The Experience of Greece as a Model to Contain COVID-19 Infection Spread
AID  - 10.21873/invivo.12380
DP  - 2021 Mar 01
TA  - In Vivo
PG  - 1285--1294
VI  - 35
IP  - 2
4099  - http://iv.iiarjournals.org/content/35/2/1285.short
4100  - http://iv.iiarjournals.org/content/35/2/1285.full
SO  - In Vivo2021 Mar 01; 35
AB  - The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in late 2019 and has caused a pandemic known as corona virus disease 2019 (COVID-19), responsible for the death of more than 2 million people worldwide. The outbreak of COVID-19 has posed an unprecedented threat on human lives and public safety. The aim of this review is to describe key aspects of the bio-pathology of the novel disease, and discuss aspects of its spread, as well as targeted protective strategies that can help shape the outcome of the present and future health crises. Greece is used as a model to inhibit SARS-COV-2 spread, since it is one of the countries with the lowest fatality rates among nations of the European Union (E.U.), following two consecutive waves of COVID-19 pandemic. Furthermore, niche research technological approaches and scientific recommendations that emerged during the COVID-19 era are discussed.